Sensorion (FRA:RFM) FFO


FRA:RFM Sensorion SA FRA:RFM
24 GF Score
Price €0.19
! 1 Warning Sign
View Full Analysis

What is Sensorion FFO?

FFO (Funds from operations) only applies to REITs.

FRA:RFM
24GF Score
Sensorion SA FRA:RFM
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sensorion Business Description

Other Exchanges ALSEN:FranceRFM:Germany
Address 375, rue du Professeur Joseph Blayac, Montpellier, FRA, 34080
Sensorion SA is a France-based clinical-stage biotech company, which specializes in the development of novel therapies to restore, treat, and prevent hearing loss disorders. The SENS501 (OTOF-GT) targets deafness caused by mutations of the gene encoding for otoferlin and is currently developed in a Phase 1/2 clinical study, and GJB2-GT targets hearing loss related to mutations in GJB2 gene to potentially address important hearing loss segments in adults and children. The Company is also working on the identification of biomarkers to improve diagnosis of these underserved illnesses. The company's pipeline programs are OTOF-GT (SENS-501), GJB2-GT, GJB2-GT, GJB2-GT, TREAT AND PREVENT, SENS-401 COCHLEAR, SENS-401 CIO, and SENS-401 SSNHL.
24GF Score

Get the complete analysis for FRA:RFM

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.19
Price